University of Louisville Journal of Respiratory Infections

PERSPECTIVE PIECE

Consultation/Liaison Psychiatry During COVID-19
Robert Frierson1∗ , MD; Steven Lippmann1 , MD
1

Department of Psychiatry, School of Medicine, University of Louisville, Louisville, KY, USA

∗ robert.frierson@louisville.edu

Recommended Citation: Frierson R, Lippmann S. Consultation/liaison psychiatry during COVID-19. Univ Louisville J Respir Infect 2021; 5(1):Article 33. doi:
10.18297/jri/vol5/iss1/33.

Introduction
Consultation/liaison (C/L) psychiatry is a subspecialty
that focuses on treating people with mental health disorders that co-exist with medical conditions.[1, 2] As
part of patient evaluations, the C/L psychiatrist relates
to and contends with the issues of others beside the
patient: physicians, nurses, family, visitors, and patient roommates.[3] Dealing with pain and/or preoccupation with medical concerns, as well as being surrounded by hospital alarms and monitors, creates additional obstacles to establishing rapport and empathy.
Patients are often unaware that a psychiatric consultation has been requested; they may wonder whether
their doctor questions their state of mind. The psychiatrist navigates these obstacles and tries to create an environment conducive to everyone being cooperative.[1]
This is not easy. The responsibilities of the C/L psychiatrist include evaluations after a suicide attempt or
for suspected suicidal ideation or plans; they also manage psychiatric sequelae resulting from medical conditions (e.g., delirium), provide care for pre-existing mental disorders, assess decisional capacity, and treat substance abuse, including withdrawal states. Providing
liaison and support to the medical and nursing staff is
also important.[4]
In performing a clinical evaluation, the consultant reviews the medical record and discusses the case with
the referring physician and nursing staff. They assess the patient, review findings and recommendations with the attending doctor, record documentation,
and set potential follow-up arrangements.[1] Thus,
the psychiatrist assesses the situation and the illness
and/or emotions involved, suggests therapeutic interventions, and provides coordination.[1] To paraphrase
Sir William Osler, “The physician can cure sometimes,
relieves often, but comforts always.”

fected and for anyone who employs protective measures such as social isolation, quarantine, and/or
widespread lockdowns.[5, 6]

Psychologic
Patients

Stressors

for

COVID-19

This pandemic has had discomforting implications for
the psychosocial well-being of patients and medical
caregivers. Stressors for those hospitalized for coronavirus infections include fear of infecting family and
lost social support coping mechanisms, especially due
to restricted hospital visitation. Pre-existing psychiatric
disorders are often made worse—anxiety and dysphoria emerge with unemployment, school closings, inperson schooling, and housing problems; many also
mourn loss of intimacy with their doctor due to the use
of personal protective equipment (PPE) or remote communication via electronic devices. Some people complain about sleep deprivation and/or phobias about
not awakening. People also report flashbacks and
nightmares related to procedures such as intubation.
Waiting for COVID-19 test results that may confirm
infection and concern about whether they would be
immune to future infection is also stressful. Oversaturation with pandemic-related news is common and
troublesome. Many individuals are worried about substance abuse relapses, the uncertainty of recovery, and
the fear of dying alone—concern about their uncertain
prognosis and the fear of dying alone are particularly
stressful (see Table 1). The psychiatric consultant must
identify and try to mitigate these concerns while at the
same time managing their own dread about contracting
the illness and continuing to provide support to their
medical colleagues.

The COVID-19 pandemic has created many economic,
psychosocial and mental health difficulties for those af-
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Table 1. Stressors for patients.

Fear of having exposed family members
Being ill without family visitation
Loss of intimacy with medical caregivers
Fewer coping mechanisms
Worsening past psychiatric disorders
Helplessness and loss of control
Substance abuse
COVID-19-related news oversaturation
Post-hospitalization placement issues
Pandemic-related socioeconomic issues
Issues over death and dying

Challenges: Psychiatric Consultant
Maintaining visibility
Like their colleagues, the C/L psychiatrist is concerned with the possibility of being infected and/or
sick with the virus. This might lead a clinician to utilize
telemedicine as their primary means of practice and
to avoid person-to person contact. However, there is
a benefit to having our medical colleagues know that
we too are on the front line of COVID-19 health care.
Visible presence also supports other clinicians and reinforces collaborative relationships. When PPE is limited, supplies must be prioritized to those most directly
involved in close patient contact, but if scarcity is less
of an issue, having the psychiatrist at the bedside lets
other clinicians know: “we are all in this together.”
They serve as good examples to other healthcare workers of the importance of personal care and that it can be
done safely.

ments. Psychologic effects of decreased intimacy in
caring for individuals with COVID-19 is reminiscent
of the early days of the AIDS epidemic, when a handshake from the physician often precipitated tearfulness
since people were afraid of acquiring HIV through contact.[7, 8] Some helpful interventions to address this
loss of intimacy include gaining permission to enter the
patient’s room, starting the conversation sitting at eye
level, making an effort to ensure privacy, and offering
reassurance that all communication will be done in person.
Managing
conditions

exacerbation

of

1. Concern about prognoses

“I wish I could see your face,” one patient said to a
consulting psychiatrist; this illustrates one difficulty of
COVID-19 restrictions. Telecommunication is replacing in-person bedside healthcare, adversely affecting
the therapeutic relationship with distractions less noticed at face-to face encounters. Physician instructions
imparted at the bedside may be better followed than
those conveyed by telecommunication. Diminished intimacy with a psychiatrist is of particular concern because patients already feel isolated from family, friends,
co-workers, classmates, religious caregivers, and others. Appreciative patients may offer a handshake only
to be reminded that touching is not advisable during
this pandemic. Even with the psychiatrist at the bedside, other relationship barriers include masks, face
shields, goggles, gowns, and gloves. This garb conveys
the message, “I must not get close to you.”

2. Socio-economic worries
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psychiatric

Anxiety: Most COVID-19-related psychiatric consultations are for management of anxiety, and anxiety disorders were common to many of the affected individuals. The most common contributors to patients’ anxiety
are:

Loss of intimacy

Loss of intimacy is worse when caring for elderly people, for whom a gentle touch is comforting; they are
often uncomfortable with electronic devices; paranoid
patients are even more suspicious about such instru-

pre-existing

3. Concerns about family members being exposed to
the virus
4. Anxiety caused by restricted visitation policies
5. Suboptimal communication with medical providers
6. Unavailability of established coping methods
7. Fear of not being able to breathe (despite normal
oxygen saturation)
8. Pain
9. Helplessness and loss of control
Patients with COVID-19 exposure and obsessive/compulsive disorder struggle with loss of control and inability to engage in ritualistic behaviors that
were previously stress relievers. Those with panic disorders may become overly focused on somatic symptoms, convinced that such panic-related features as
chest tightness, shortness of breath, or rapid heart rate
2
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Table 2. Challenges for the psychiatrist.

Fear of self-contagion and/or infecting family
Maintaining a hospital presence
Supporting medical and nursing staff
Combating helplessness
Managing pre-existing and/or current psychiatric problems
Watching people die without family presence
Shortages of personal protective equipment
Conveying empathy despite telecommunication
Combating stigmatization of patients infected by COVID-19
Dealing with substance use issues
Assessing decisionality for COVID-19 patients
Attending to self care

are dangerous harbingers of deteriorating health. Individuals with claustrophobia beg not to be confined
to their room with doors closed. Some people evidence acute stress and/or post-traumatic stress disorders with nightmares and flashbacks related to events
such as intubation. Individuals with sleep disorders
sometimes develop a sleep phobia, with fear of death
during the night; sleep deprivation can worsen their
overall status and lead to delirium.
Patients with anxiety disorders and COVID-19 infections may become worse when prescribed a corticosteroid or sympathomimetic drug. Pulmonary status
may limit the prescribing of pharmacotherapies, such
as benzodiazepines; those previously taking them must
be monitored for withdrawal. For mild anxiety symptoms, antihistamines are often employed, but their application for older people increases the risk of delirium.
Dexmedetomidine is often prescribed to calm severe
anxiety or agitation unresponsive to other medications.
Anxiety is expected among people suffering from a disease about which little is known. Persons with preexisting anxiety are likely to have more intense emotional responses. The challenge in caring for these
patients includes providing psychotherapies that empower them and promote autonomy. Open communication between patients and medical caregivers is usually reassuring. When able to ask questions of their
providers, individuals can combat helplessness and
feeling out of control. In providing care for such anxious persons, the C/L psychiatrist should:
1. Provide psychotherapy to empower active participation in medical care.
2. Be a patient advocate regarding issues such as pain
control.
3. Encourage them to be grateful for incremental
progress.
4. Support and debrief nurses to improve interactions,
especially for staff who are anxious, stressed, inexperienced, and/or fearful of contagion.
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5. Employ pharmacotherapies and behavioral interventions.
6. Utilize persons who have recovered from COVID-19
illness as peer supporters.
Depression: “I’m not suicidal,” a depressed patient
told a psychiatrist, “but I hope to die from COVID.”
Depression is a common reason for psychiatric consultations. Dysphoria is more intense among those with
previous mood disorders. They often express concern
about family members getting sick and missing their
presence at the bedside. Many were already despondent because of unemployment and financial concerns.
While people rarely express suicide intent solely related to COVID-19 positivity, some report conditional
suicidal thoughts, such as “if I have to live with this
pain, I’ll just kill myself.” Some of them require continuous, one-to-one, direct observation to prevent selfharm; this creates additional stress for the patient, the
psychiatrist, and staff, since a staff member must be
present to monitor the person for a prolonged time. The
psychiatrist may be conflicted about ordering such observation for fear of putting hospital personnel at infection risk. Mitigating depression is complicated since
antidepressant medications often have a delayed onset of action. Some have drug interactions and anticholinergic effects, which might produce a delirium.
Some seriously ill patients might be intubated, precluding oral intake. Psychostimulant drugs such as
methylphenidate are occasionally indicated because of
a more immediate onset of action.[9]
Another challenging issue is the management of depressed COVID-19-positive patients who are medically
stable but in need of psychiatric hospitalization. Some
mental health facilities have opened COVID-19 wards,
making continuity of care possible. During this pandemic, psychiatrists often treat depressed COVID-19positive persons with supportive psychotherapy designed to maintain hope, celebrate signs of progress,
and develop new coping strategies. The consistent
presence of a supportive, non-judgmental caregiver can
substantially elevate mood.
3
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Substance abuse disorders: A damaging consequence of this pandemic is its influence facilitating substance abuse disorders.[10] Many people have a tenuous grip on sobriety, so decreased support, less social
connection, and financial shortage are dangerous risk
factors for drug relapse. Chemical dependency makes
all aspects of medical services more complicated. The
absence of in-person therapeutic systems, such as Alcoholics or Narcotics Anonymous meetings, and personal encounters with sponsors can have devastating
consequences, including relapse and overdose. Some
COVID-19 patients with chemical dependency complain of stigmatization by medical or nursing staff, and
this loss of trust makes healthcare delivery more difficult. In such circumstances, advocating on behalf of
patients and discussing clinical frustrations with the
medical team is often helpful. For anyone with history
of opiate abuse, analgesic dosages may require adjustment due to high tolerance. The use of buprenorphine
can be helpful in managing pain while also preventing opiate withdrawal. In general, the prescription of
controlled pharmaceuticals increases the likelihood of
drug relapse after discharge. The consultant should
therefore minimize prescription of potentially addictive agents for such conditions as anxiety and sleep difficulties.
Poor coping skills, a desire for immediate gratification,
disrupted family relationships, and isolation-induced
lonesomeness and boredom are other issues that must
be addressed. While intoxicated, inappropriate behavior may have occurred, for which the patient, once
sober, feels guilt. Some patients may wish to apologize
for certain actions. Such concerns were heightened by
the pandemic since stress levels were higher, and substance abuse issues were more prevalent. Open discussion should provide some comfort. Treatment for drug
dependence, possibly with family counseling, should
always be provided as well. Psychiatrists should have
some knowledge of relapse warning signs and make
use of such individuals as harm reduction healthcare
personnel, many of whom are themselves in recovery.
Hospital chaplains are beneficial, especially when there
are spiritual issues.
Delirium: Delirium can be caused by infections,
metabolic derangement, hypoxemia, sleep deprivation,
pain, medicinal effects, drug withdrawal, postoperative complications, cerebrovascular events, intensive
care unit sensory overload, and for people with dementia, being in an unfamiliar environment. Psychiatrists
often manage patient behavior associated with these issues while the medical team investigates and/or treats
the underlying ailment.[11] Many of these conditions
complicate COVID-19 patient care. Evidence for central nervous system pathology induced by coronavirus
infection is inconclusive with regard to predisposition
for and persistence of neurologic features.[12]
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COVID-19-mandated restrictive family visitation policies are another burden; contact with relatives could
mitigate the need for pharmacotherapies.[13] Management of patients with delirium emphasizes having a familiar environment for patients, but this is difficult to
provide in this pandemic era. Nocturnal accentuation
of confusion (“sundowning”) often leads to sleep deprivation, which can intensify delirium, and electronic
communication devices can cause discomfort for older
persons and anyone who is already psychotic or paranoid.[14] Patients with encephalopathy evidence more
comfort when family or a familiar person are at the bedside. The consistent presence of the psychiatrist provides greater stability, too. Finally, the consultant may
have to determine decisionality for COVID-19 patients
who refuse treatment or insist on leaving the hospital
against medical advice. In these instances, they must
balance patient rights against the potential threat to society posed by a COVID-19-positive patient who might
not possess the cognitive ability or judgment to comply
with social distancing, mask wearing, and other preventive measures. Care of a COVID-19 patient with
cognitive impairment represents a significant challenge
for the consulting psychiatrist.
Maintaining staff morale: Morale is a concern particularly among nurses. Beyond caring for critically ill
patients, they must cope with COVID-19-related issues,
such as repeated calls from family members unable to
visit, increased workloads, and shortages of PPE. Staff
shortages result from personnel who are ill or quarantined. It is demoralizing to care for critically ill patients
who seek medical care late in their course of illness due
to COVID-19 infection fears. Healthcare workers thus
experience frustration while being overworked and
emotionally taxed. The psychiatrist should spend time
with the hospital staff, exploring their issues through
debriefing and discussion. Making appreciative comments about dedicated service and inquiring about the
health and well-being of family members reaps a social
dividend; it also improves all hospital and patient interactions. This is especially important for anyone providing care for cognitively impaired patients who may
be non-compliant, verbally abusive, or combative. The
simple question, “What’s been your experience taking
care of this patient?” can lead to a conversation that
significantly boosts morale. Improving the quality of
healthcare by attending to staff morale secondarily also
promotes the psychiatrist’s sense of well-being.
Combating helplessness: Psychiatrists are not alone
in feeling helplessness about this disease. There is
agony in watching patients die, especially if they are
alone.[13] There is limited understanding about the adverse effects or interactions of psychiatric medications
co-prescribed with antiviral agents, such as remdesivir.
Fear of personally becoming ill and potentially infecting family members creates stress and helplessness.
“I am afraid of taking this illness home to my fam-
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ily,” is often heard.[15] Shortages of, or not trusting
in, PPE and impersonal means of communicating also
contribute. Pulmonologists, critical care, and infectious
diseases physicians are not immune to these feelings,
so one should not assume that they are.
Usually, returning home offers a respite from patient care worries; however, COVID-19 care providers
prominently maintain the fear that they might convey
a viral infection to those at home. Balancing a sense
of obligation to provide care for hospitalized patients
while wanting to protect family creates a dilemma for
all physicians, including the mental health caregiver.
The psychiatrist should focus on fixable things. Examples include improving communication between patients and caregivers, reassuring physicians and patients by her presence, alleviating patients’ mental issues, being up to date on COVID-19 matters, attempting to improve the quality of whatever life remains, offering hope and combating pessimism, and realizing
that she is not alone in her feelings of powerlessness
with regard to this pandemic. Once back home, it is
important to maintain protective precautions such as
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frequent handwashing, leaving shoes and outer garments outside, changing into clean clothing, and isolating when indicated. To avoid physician burnout, maintaining routines of a healthy diet, regular exercise, and
avoiding substance use is important. Utilizing spiritual
advisors, maintaining sleep, and taking vacations or
time off also help.[16] In combating pandemic-related
helplessness, the consulting psychiatrist will be well
served to accept the things he cannot change, change
the things he can, and acquire the wisdom to know the
difference.

Conclusion
Providing psychiatric consultation for someone infected by COVID-19 is similar to treating hospitalized patients with any medical or psychiatric condition.
There are, however, circumstances created by this pandemic that are unique; the psychiatrist ought to recognize these issues and respond while attending to their
own frustrations. Providing good professional work
and appropriate self-care is key. Doing so and being appreciative of clinical progress can empower physicians
and everyone involved.
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